News About: Pharm. Industry
Drugmaker’s group in turf war over leadership
The Korea Pharmaceutical Manufacturers Association is still staggering over an internal feud on whether to acknowledge its newly-elected leader.
According to sources, Yoon Suk-geun, who was nominated the new presid...
Pharmaceutical firms stash cash as outlook stays gloomy
Domestic pharmaceutical firms are holding sufficient amounts of cash – an indication that they are growing more pessimistic over the outlook for future economic and profits growth, data showed Monday.
Yakup.com, a ...
Pharmaceutical firms suffer decline in 2011 operating profit
Korea’s pharmaceutical companies saw their operating profits plummet in 2011 on a fiercer competition among drug makers, data showed Monday.
According to the data compiled by Yakup.com, a corporate information prov...
AstraZeneca Korea names Chae hyuk new vice president
AstraZeneca Korea announced Monday that Chae hyuk, the company’s executive for personal management, had been appointed as new vice president of Asian Headquarters in AstraZeneca.
Along with Chai, two executives wer...
Hanmi forges strategic tie-up with SK Biopharm
Hanmi Pharmaceutical Co. said Monday it established a strategic partnership with SK Biopharmaceuticals Co. to sell a diazepam-containing nasal spray epilepsy drug in Korea and China.
Under the deal, Hanmi and its C...
Pharmaceutical firms see operating profit plunge in 2011
Most of Korea's drug makers saw their earnings fall last year amid dramatic changes in the business environment such as regulations by the government and intense competition among generic drugs, data showed Monday.
...
Few rewards for innovation
The main reason why companies want the pharmaceutical market and the pricing and reimbursement system to be predictable and transparent is that pharma R&D investment is very long-term and carries a significant risk of...
Drug makers keen on innovative pharmaceutical firms
Local drug firms have been vying to be designated as innovative firms as the government pledged to select 50 companies as “innovative pharmaceutical firms,” subject to tax deduction, price raises, financial aid, resea...
Pyramax Phase 3 study results published in New England Journal of Medicine
Results from a Phase 3 study of pyronaridine-artesunate combination pill Pyramax, approved by EMA for the treatment of falciparum malaria, was published in the New England Journal of Medicine dated April 5, Shinpoong ...
Daewoong to set up JV for pharmaceutical plant in Indonesia
Daewoong Pharmaceutical Co. said Tuesday that it plans to establish a joint venture with PT. Infion, an affiliated company of PT. Bernofarm in Indonesia, to build a cGMP (current Good Manufacturing Practice) pharmaceu...
